Right Ventricular Endocardial Mapping and a Potential Arrhythmogenic Substrate in Cardiac Amyloidosis—Role of ICD

Patients with cardiac amyloidosis (CA) have an increased risk of sudden cardiac death. (SCD). However, the role of an implantable cardioverter-defibrillator in the primary prevention of SCD in this group of patients is still controversial. We present a case with CA with recurrent syncope and non-sus...

Descripción completa

Detalles Bibliográficos
Autores principales: Liżewska-Springer, Aleksandra, Królak, Tomasz, Dorniak, Karolina, Kempa, Maciej, Dąbrowska-Kugacka, Alicja, Sławiński, Grzegorz, Lewicka, Ewa
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8583432/
https://www.ncbi.nlm.nih.gov/pubmed/34770146
http://dx.doi.org/10.3390/ijerph182111631
Descripción
Sumario:Patients with cardiac amyloidosis (CA) have an increased risk of sudden cardiac death. (SCD). However, the role of an implantable cardioverter-defibrillator in the primary prevention of SCD in this group of patients is still controversial. We present a case with CA with recurrent syncope and non-sustained ventricular tachycardia. In order to further stratify the risk of SCD, an electrophysiological study with endocardial electroanatomic voltage mapping was performed prior to the ICD placement.

Ejemplares similares